Michael S Perry - Net Worth and Insider Trading

Michael S Perry Net Worth

The estimated net worth of Michael S Perry is at least $4 Million dollars as of 2024-04-20. Michael S Perry is the Director of AVITA Medical Inc and owns about 229,543 shares of AVITA Medical Inc (RCEL) stock worth over $2 Million. Michael S Perry is the Director of Arrowhead Pharmaceuticals Inc and owns about 85,500 shares of Arrowhead Pharmaceuticals Inc (ARWR) stock worth over $2 Million. Michael S Perry is also the Director of Armata Pharmaceuticals Inc and owns about 29,381 shares of Armata Pharmaceuticals Inc (ARMP) stock worth over $78,300. Details can be seen in Michael S Perry's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Michael S Perry has not made any transactions after 2022-11-21 and currently still holds the listed stock(s).

Transaction Summary of Michael S Perry

To

Michael S Perry Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael S Perry owns 5 companies in total, including AVITA Medical Inc (RCEL) , Arrowhead Pharmaceuticals Inc (ARWR) , and Armata Pharmaceuticals Inc (ARMP) among others .

Click here to see the complete history of Michael S Perry’s form 4 insider trades.

Insider Ownership Summary of Michael S Perry

Ticker Comapny Transaction Date Type of Owner
RCEL AVITA Medical Inc 2022-11-21 director & Chief Executive Officer
ARWR Arrowhead Pharmaceuticals Inc 2022-01-03 director
ARMP Armata Pharmaceuticals Inc 2019-12-31 director
PARD Poniard Pharmaceuticals Inc 2012-03-27 President & CMO
XENO Xeno Transplants Corp 2007-05-03 director

Michael S Perry Latest Holdings Summary

Michael S Perry currently owns a total of 3 stocks. Among these stocks, Michael S Perry owns 229,543 shares of AVITA Medical Inc (RCEL) as of November 21, 2022, with a value of $2 Million and a weighting of 49.95%. Michael S Perry owns 85,500 shares of Arrowhead Pharmaceuticals Inc (ARWR) as of January 3, 2022, with a value of $2 Million and a weighting of 48.08%. Michael S Perry also owns 29,381 shares of Armata Pharmaceuticals Inc (ARMP) as of March 22, 2018, with a value of $78,300 and a weighting of 1.97%.

Latest Holdings of Michael S Perry

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RCEL AVITA Medical Inc 2022-11-21 229,543 8.64 1,983,252
ARWR Arrowhead Pharmaceuticals Inc 2022-01-03 85,500 22.33 1,909,215
ARMP Armata Pharmaceuticals Inc 2018-03-22 29,381 2.67 78,300

Holding Weightings of Michael S Perry


Michael S Perry Form 4 Trading Tracker

According to the SEC Form 4 filings, Michael S Perry has made a total of 5 transactions in AVITA Medical Inc (RCEL) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in AVITA Medical Inc is the sale of 150,000 shares on November 21, 2022, which brought Michael S Perry around $1 Million.

According to the SEC Form 4 filings, Michael S Perry has made a total of 4 transactions in Arrowhead Pharmaceuticals Inc (ARWR) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Arrowhead Pharmaceuticals Inc is the sale of 4,500 shares on January 3, 2022, which brought Michael S Perry around $291,195.

According to the SEC Form 4 filings, Michael S Perry has made a total of 0 transactions in Armata Pharmaceuticals Inc (ARMP) over the past 5 years. The most-recent trade in Armata Pharmaceuticals Inc is the acquisition of 20,900 shares on March 22, 2018, which cost Michael S Perry around $198,963.

Insider Trading History of Michael S Perry

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Michael S Perry Trading Performance

GuruFocus tracks the stock performance after each of Michael S Perry's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael S Perry is 5.17%. GuruFocus also compares Michael S Perry's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael S Perry within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Michael S Perry's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Michael S Perry

Average Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -0.86 5.17 -20.87 -71.55 -58.9 -31.04
Relative Return to S&P 500(%) -1.86 0.96 -31.69 -77.49 -52.26 -45.26

Michael S Perry Ownership Network

Ownership Network List of Michael S Perry

No Data

Ownership Network Relation of Michael S Perry


Michael S Perry Owned Company Details

What does AVITA Medical Inc do?

Who are the key executives at AVITA Medical Inc?

Michael S Perry is the director & Chief Executive Officer of AVITA Medical Inc. Other key executives at AVITA Medical Inc include CFO David D O'toole , General Counsel Donna Shiroma , and Chief Financial Officer Michael Holder .

AVITA Medical Inc (RCEL) Insider Trades Summary

Over the past 18 months, Michael S Perry made 1 insider transaction in AVITA Medical Inc (RCEL) with a net sale of 150,000. Other recent insider transactions involving AVITA Medical Inc (RCEL) include a net purchase of 16,700 shares made by David D O'toole , a net sale of 5,018 shares made by Jeremy Curnock Cook , and a net sale of 4,193 shares made by Donna Shiroma .

In summary, during the past 3 months, insiders sold 0 shares of AVITA Medical Inc (RCEL) in total and bought 1,250 shares, with a net purchase of 1,250 shares. During the past 18 months, 160,656 shares of AVITA Medical Inc (RCEL) were sold and 16,700 shares were bought by its insiders, resulting in a net sale of 143,956 shares.

AVITA Medical Inc (RCEL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

AVITA Medical Inc Insider Transactions

No Available Data

Michael S Perry Mailing Address

Above is the net worth, insider trading, and ownership report for Michael S Perry. You might contact Michael S Perry via mailing address: C/o Biotransplant Inc, 196 Boston Ave Suite 2800, Medford Ma 02155.

Discussions on Michael S Perry

No discussions yet.